UNSPSC 51261501: Ancarolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C18H24N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 00EED65INL, chemically known as (r,s)-2-(3-(tert-butylamino)-2-hydroxypropoxy-2-furanilid but generally known as ancarolol, which bears US NIH Compound Identifier 170339. European Medicines Agency schedules Ancarolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05506MIG. The term ANCAROLOL is an International Non-Proprietary Name.

UNSPSC 51261501 Ancarolol is a Commodity code that encompasses pharmaceutical products, but recent state and local solicitations show minimal alignment with the code's nominal scope. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for community health initiatives, with quarterly deliveries and a two-year initial term plus one-year renewal option. The Texas Health and Human Services Commission posted Request for Information HHS0017013 in April 2026 to gather vendor capabilities on direct-to-manufacturer prescription fulfillment programs outside traditional pharmacy benefit manager channels, seeking strategies for value-based contracting and volume fulfillment. Neither opportunity directly addresses ancarolol as a procured pharmaceutical; instead, the code shows recent activity concentrated on naloxone distribution and pharmacy network modernization.

Activity under this code is geographically limited to the evidence presented: Florida and Texas are the only jurisdictions with posted opportunities in the recent data. Issuing bodies include county health departments and state pharmacy benefit administrators rather than a broad mix of municipalities or school districts. The Seminole County IFB (due July 26, 2023, per the source posting) targets fixed-fee procurement with standard compliance requirements including drug-free workplace certification and E-Verify, potentially funded through FEMA. The Texas RFI functions as preliminary market intelligence rather than a formal competitive solicitation, with no budget, award value, or binding timeline specified. Neither opportunity names explicit set-asides for disadvantaged enterprises. The code shows limited recent activity, and when present, that activity does not consistently map to ancarolol as a product category.